November 27, 2017 / 12:40 PM / 14 days ago

BRIEF-Protalix Presents Positive Results From Phase I/II Trial For PRX-102

Nov 27 (Reuters) - Protalix Biotherapeutics Inc:

* PROTALIX BIOTHERAPEUTICS PRESENTS POSITIVE RESULTS FROM THE PHASE I/II OPEN-LABEL EXTENSION TRIAL FOR PRX-102 AT THE NEW HORIZONS FOR FABRY DISEASE CONFERENCE Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below